Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...